JULIETTE HOANG: Open Payments
NPI 1881179778 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 80 payments from 18 companies in 2025. Trend: 2023 $2,681 · 2024 $2,344 · 2025 $1,839
Food & beverage: $1,829Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $362 |
| GENZYME CORPORATION | 5 | $316 |
| LEO Pharma Inc. | 9 | $160 |
| Amgen Inc. | 8 | $146 |
| PFIZER INC. | 10 | $144 |
| UCB, Inc. | 6 | $136 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Organon LLC | 4 | $58 |
| Lilly USA, LLC | 2 | $53 |
Products named: SKYRIZI, DUPIXENT, OTEZLA, Bimzelx, DAXXIFY, CIBINQO, ADBRY, BOTOX.
Industry payments across NV — which companies pay providers there.
